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ABSTRACT We discovered a new lineage of the globally important fungal patho-
gen Cryptococcus gattii on the basis of analysis of six isolates collected from three
locations spanning the Central Miombo Woodlands of Zambia, Africa. All isolates
were from environments (middens and tree holes) that are associated with a small
mammal, the African hyrax. Phylogenetic and population genetic analyses confirmed
that these isolates form a distinct, deeply divergent lineage, which we name VGV.
VGV comprises two subclades (A and B) that are capable of causing mild lung infec-
tion with negligible neurotropism in mice. Comparing the VGV genome to previ-
ously identified lineages of C. gattii revealed a unique suite of genes together with
gene loss and inversion events. However, standard URA5 restriction fragment length
polymorphism (RFLP) analysis could not distinguish between VGV and VGIV isolates.
We therefore developed a new URA5 RFLP method that can reliably identify the
newly described lineage. Our work highlights how sampling understudied ecological
regions alongside genomic and functional characterization can broaden our under-
standing of the evolution and ecology of major global pathogens.
IMPORTANCE Cryptococcus gattii is an environmental pathogen that causes severe
systemic infection in immunocompetent individuals more often than in immuno-
compromised humans. Over the past 2 decades, researchers have shown that C. gat-
tii falls within four genetically distinct major lineages. By combining field work from
an understudied ecological region (the Central Miombo Woodlands of Zambia, Af-
rica), genome sequencing and assemblies, phylogenetic and population genetic
analyses, and phenotypic characterization (morphology, histopathological, drug-
sensitivity, survival experiments), we discovered a hitherto unknown lineage, which
we name VGV (variety gattii five). The discovery of a new lineage from an under-
studied ecological region has far-reaching implications for the study and under-
standing of fungal pathogens and diseases they cause.
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Cryptococcosis is a severe fungal infection responsible for high levels of mortalityand morbidity worldwide (1). The etiological agents are two species complexes of
the genus Cryptococcus: Cryptococcus neoformans and C. gattii. While the first described
cases of clinical cryptococcosis due to these two distinct species complexes were
reported in the mid-1890s under the names Saccharomyces hominis (2) and S. subcu-
taneous tumefaciens (3), respectively, clinical Cryptococcus isolates have been taxonom-
ically treated as a single species (C. neoformans) for more than 100 years (4). Hetero-
geneity among cryptococcosis-causing yeast isolates became increasingly apparent
from the middle of the 20th century onward and led to the recognition of four
serotypes (A, B, C, and D) on the basis of the antigenic determinant of capsular
polysaccharide (5, 6). Subsequent discovery of two distinct sexual cycles produced by
the isolates of serotypes A and D versus serotypes B and C (7, 8) and phylogenetic
analysis using various gene sequences (9–11) confirmed these complexes to be genet-
ically divergent enough to be considered separate species. Thus, in 2002, the isolates
of serotypes B and C were formally classified as C. gattii (12) while C. neoformans
includes all serotype A and D strains (13).
Over the past 2 decades, population structure analysis of the two species using
molecular typing methods such as PCR fingerprinting (14), amplified fragment length
polymorphism (AFLP) analysis (15), and multilocus sequencing (16) has demonstrated
that both species contain genetically diverse lineages that qualify them to be consid-
ered two species complexes, and those species complexes have been further subdi-
vided into numerous molecular types (14, 17). To date, four major lineages, denoted
VGI/AFLP4, VGII/AFLP6, VGIII/AFLP5, and VGIV/AFLP7, are recognized for C. gattii.
Recently, a fifth genotype was described on the basis of a single strain but with several
different designations, including clade B (based on multilocus sequence typing [MLST]),
VGIIIc/VGIV, and C. decagattii (17, 18). Elevation of these five lineages to separate
species has been proposed previously (17). However, such taxonomic treatment is
currently controversial, mainly due to the lack of clear biological differences between
the lineages and of a clear consensus with respect to the limits and numbers of the
putative species boundaries. As such, the various C. gattii lineages are collectively
considered the “C. gattii species complex” (18).
In this paper, we describe the discovery of a new lineage/molecular type within the
C. gattii species complex, which we designate VGV (variety gattii five). The six VGV
isolates were identified among 32 C. gattii isolates recovered from soil, animal dung,
and tree bark samples collected in Zambia by Vanhove et al. in 2013 (19). In this paper,
we characterize genomic and phenotypic features of the VGV molecular type. Addi-
tionally, we present a new, improved genome assembly and gene sets for C. decagattii
(17) which we confirmed for the first time to represent a separate lineage and which we
therefore name “VGVI” for consistency with the other lineages.
RESULTS
Comparative and population genomics for the six lineages of C. gattii. We
discovered a new lineage of Cryptococcus gattii from a panel of 32 (of 55) genome-
sequenced isolates recovered from Southern tree hyrax (Dendrohyrax arboreus) mid-
dens, midden soil, or tree holes from the Central Zambezian Miombo Woodland
ecoregion, a densely forested ecoregion that covers much of Central and East Africa
(Fig. 1) (Table 1; see also Table S1 in the supplemental material). Isolates from the new
lineage, which we have named VGV, were collected from a 430-km span of northern
Zambia, including the Mupata Hills (Luanshya, Copperbelt Province), Mutinondo Wil-
derness area, and Kapishya (Mpika, Northern Province), suggesting that the lineage has
a broad regional distribution across this ecoregion (Fig. 1A). All VGV isolates were
identified as serotype B, which also encompasses strains from VGI, VGII, the VGIIIa
subgroup, and rare isolates among VGIV strains.
Phylogenetic analyses demonstrated that VGV and VGVI (C. decagattii) and the four
previously described lineages are genetically distinct from each other (Fig. 2). Indeed,
none of the C. gattii lineages appear to be the result of hybridization based on the
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distribution of private alleles (i.e., alleles not shared between lineages) (Fig. 3a and b),
maximum likelihood phylogenetic reconstruction (Fig. 2a), Wright’s fixation index (FST)
(see Fig. S4 in the supplemental material) or NeighborNet Network data (Fig. 2b).
Additional population genetics analyses confirmed low levels of genetic exchange
between the six well-resolved C. gattii lineages. For example, principal-component
analysis (PCA) resolved distinct grouping for the lineages, with the first component
(PC1) separating VGII from all other lineages, forming distinct clusters for VGIII and VGVI
on PC2 (Fig. 2c). The projection of PC3 and PC4 further allowed identification of distinct
tight clusters for the VGI, VGIV, and VGV lineages (Fig. 2d).
The new VGV lineage is represented by six isolates falling within two distinct
subclades (A and B). Clade A comprises three VGV isolates (MF5, MF13, and MF54) that
were recovered from soil and animal dung sampled in hyrax middens, from which we
also identified VGI and VGII isolates (Fig. 1a). Clade B comprises a further three VGV
isolates: two (MF34 and MF51) that were recovered approximately 345 km away from
clade A and a third (MF56) that was recovered approximately 430 km away from the
other clade B isolates. Clade B isolates were recovered from both a tree hole and hyrax
FIG 1 Environmental sampling of C. gattii VGV in Zambia. (A) Location of C. gattii VGV isolates across Central Zambian Miombo Woodlands. Isolates MF5, MF13,
and 54 (Mupata Hills, Copperbelt province) and MF56 (Kapishya, Northern Province) were found in or near Hyrax middens created by Southern tree hyrax
(Dendrohyrax arboreus). MF34 and MF51 were found from sampling Miombo tree holes in the Mutinondo wilderness area, Northern Province. (B) A tree hyrax
feeding on leaves. (C) Sampling from hyrax middens at Kapishya from which MF56 was isolated.
TABLE 1 Environmental isolates of VGIV and VGV from the Central Zambezian Miombo
Woodlands
Isolate Source Location Latitude Longitude VG type Serotype
MF5 Hyrax midden Mupata Hill 13.12 28.18 VGV B
MF13 Hyrax midden Mupata Hill 13.12 28.18 VGV B
MF34 Tree hole Mutinondo 12.45 31.29 VGV B
MF51 Tree hole Mutinondo 12.45 31.29 VGV B
MF54 Hyrax midden Mupata Hill 13.12 28.18 VGV B
MF56 Hyrax midden Kapishya 11.16 31.60 VGV B
MF46 Hyrax midden Mutinondo 12.48 31.32 VGIV C
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FIG 2 Whole-genome analysis supports classification of VGV as a distinct lineage. (a) Maximum likelihood (RAxML)
phylogeny of 101 C. gattii genomes generated over all nonambiguous sites with at least one SNP in at least one isolate
(1,518,323 sites, or 8.7% of the total genome). Isolate names are colored according to lineage (dark blue  VGI, green 
VGII, purple VGIII, light blue VGIV, orange VGV, and red VGVI). Asterisks indicate 100% bootstrap support at each
node corresponding to 1,000 tree-building replicates. (b) SplitsTree NeighborNet Network. (c and d) Principal-component
analysis (PCA) of genomic variant sites, showing separation of isolates into lineages (isolates are plotted with 2% random
noise [jitter] for clarity of individual points). The first four principal components (PC1 and PC2 [c] and PC3 and PC4 [d])
account for 71.26% of the total genetic variation.
Farrer et al. ®
November/December 2019 Volume 10 Issue 6 e02306-19 mbio.asm.org 4
 o
n
 N
ovem
ber 12, 2019 at UNIVERSITY O
F EXETER
http://m
bio.asm
.org/
D
ow
nloaded from
 
middens, showing that the lineage can occupy both tree and dung, environments that
are both associated with hyrax activity. The fact that clades A and B were found in
different geographic locations might reflect the degree of spatial genetic structure
within VGV. All the VGV isolates were located in regions of the granite and acidic
kopjes/hills that are found occurring patchily across this ecoregion.
C. gattii VGV is highly divergent from all previously recognized C. gattii lineages. VGV
isolates differ from VGII (reference isolate R265) by 0.75 million single nucleotide
polymorphisms (SNPs) on average (44 SNPs/kb); thus, those isolates and the other
lineages are similarly distant from VGII (Table S1). Analysis of the relative proportions of
shared private alleles for the C. gattii lineages (Fig. 3a and b) indicates that VGII shared
the fewest alleles (4.6 kb total; 0.2 SNPs per kb) (Fig. 2 and Fig. 3a) with any of the
other lineages, reflecting its greater divergence. The newly discovered VGV lineage
shared fewer alleles with VGVI (0.24 per kb) and VGIII (0.29 per kb) than with VGI (1.18
per kb) and VGIV (2.53 per kb). The lineages that shared the most private alleles were
VGVI and its closest relative, VGIII (92 kb total; 5.37 per kb), which account for an
average of 12% of all SNPs (based on alignments to VGII) found in isolates from those
lineages.
FIG 3 Population genetic analyses for each of the C. gattii lineages (based on 101 genomes). (a) Alleles shared between C. gattii lineages (SNPs per kilobase).
(b) Alleles not shared between C. gattii lineages (i.e., private alleles) (SNPs per kilobase). (c) Nucleotide diversity () within each lineage against the number of
isolates representing each lineage. (d) Admixture K optimization based on cross-validation error. (e) Unsupervised ADMIXTURE clustering analysis of all isolates
at K 9. (f) Lineage-specific gene counts and lineage-specific gene loss counts. The tree topology is based on the core ortholog RAxML tree, setting equal
branch lengths, and the numbers of multilineage-specific gene gains and losses are shown above internal nodes.
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Nearly 1 in 10 nucleotides in the C. gattii genome has an alternative allele across the
six lineages (1.55 106 sites; 9.01% of the C. gattii genome). Indeed, 180 kb of these
unique/private alleles were identified for each lineage, including for VGV, which had
220-kb private alleles (12.75 per kb) (Fig. 3b). VGI is the most distinct in terms of both
the highest count of private alleles (378 kb/21.93 SNPs per kb) and its nucleotide
diversity () (Fig. 3c), which is reflected in the three distinct subclades of VGI isolates in
the whole-genome phylogeny (Fig. 2a and b). Conversely, the three VGVI isolates are
thought to be derived from a single isolate recovered from a patient in Mexico and
subsequently distributed to different laboratories where they have been renamed and
sequenced (14, 17, 20, 21). Its few clonal differences are illustrated by its low nucleotide
diversity () (Fig. 3c).
Unsupervised model-based clustering identified highly structured ancestry compo-
nents enriched in each of the lineages. The clustering solution with the lowest cross-
validation error value (K 9) grouped the VGV isolates into a single genetically
homogenous group (Fig. 3d and e; see also Fig. S1) while identifying four unique
components within the VGII lineage. Of these, subclades VGIIx and VGIIb share small
proportions of ancestry with other defined VGII subclades. For example, VGIIb is
inferred to share ancestry with other VGII subclades (isolates Ram5 and B8554) and
other lineages (B7394 has alleles from VGIV, and B7735 has alleles from VGV). Con-
versely, none of the isolates in VGIIa and VGIIc have a demonstrable admixture with
other subclades or lineages, both being formed by single unique ancestry components.
VGIII isolate B8212 (a clinical isolate collected in Oregon, USA, in 2007 [22]) is also
modelled as sharing ancestry with VGVI.
Finer-scale clustering was performed by considering patterns of genome-wide
haplotype sharing in fineSTRUCTURE (23). Here, VGV isolates forming a separate cluster
with greater haplotype similarity to isolates from VGI, VGIII, and VGIV than VGII (Fig. S2).
While the haplotype sharing patterns overwhelmingly accorded with each lineage
being genetically distinct, a notable exception was VGIII isolate B8212, which shares
haplotypes with VGIV and VGVI (also in accordance with model-based clustering),
perhaps owing to a small amount of genetic exchange with one or both of those
lineages. As also observed using ADMIXTURE-based clustering (Fig. 3e), two isolates
from VGII, B7394 and B7735, were also genetically distinct and were assigned to their
own cluster which was most closely related to isolates from subclade VGIIb.
All six VGV isolates were haploid, with no evidence for aneuploidy based on allele
frequencies and depth of coverage (Fig. S3). However, we did observe copy number
variation (CNV) between the three VGVI isolates derived from a single clinical isolate
from Mexico (14, 17, 20, 21). Specifically, isolate CBS11687 acquired an 200-kb
duplication of supercontig 5 (sc5) (position 1040000 through the end of the supercon-
tig). Separately, isolate WM1804 had a smaller, 40-kb duplication on sc21 (positions
150,000 to 190,000). Isolate WM1802 had neither CNV. In terms of base changes, the
three VGVI isolates (WM1802, WM1804, and CBS11687) differed by only 419 SNPs, with
the lowest number found between WM1804 and CBS11687 (n 126) and the highest
number found between WM1802 and CBS11687 (n 315). These genetic differences
may have occurred as a result of microevolution during or following passaging or
cryopreserving, although large CNVs are common in C. gattii (24, 25). All of the newly
isolated VGI (n 7) and VGVA (n 3) samples from Zambia had a small, 10-kb
duplication within supercontig 6 of the R265 genome (kb position 400 to position 410).
This genomic region encodes a single 87-amino-acid (aa) protein that is conserved in
C. neoformans and C. gattii but has no functional annotation (by PFAM, GO terms,
KEGG-EC, TMHMM, or SigP4).
The results from our phylogenetic and population genetic analyses are in line with
previous work (26), indicating that lineages within the C. gattii species complex have
remained largely genetically isolated since their divergence. Pairwise lineage calcula-
tions of , representing Weir’s formulation of Wright’s fixation index (FST), suggest very
low levels of genetic exchange between the lineages (Fig. S4), which is also reflected in
analyses of genetic structure (Fig. 2 and 3; see also Fig. S1 and S2). Both depth-of-
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coverage plots and FST nonoverlapping sliding 10-kb window plots across the mating
type locus (MAT) at the start of supercontig 18 demonstrate that all VGIV and VGV
isolates included in this study were MAT (the reference genome of R265 is MAT; high
depth of coverage and  values of 0.98 across the MAT loci). In contrast, for VGI, VGII,
VGIII, and VGVI, MATa isolates were included in our panel.
Genome assembly and analysis of VGV reveals C. gattii lineage-specific differ-
ences. We assembled and annotated a nearly complete genome for the newly discov-
ered C. gattii VGV lineage (isolate MF34) using both Oxford Nanopore and Illumina
sequencing reads. The resultant assembly consisted of 15 contigs corresponding to the
14 chromosomes; the single break in one chromosome corresponds to the ribosomal
DNA (rDNA) region. Other than underrepresenting rDNA genes, this assembly provides
a complete representation of the genome, with telomeric repeats (TTAGGG) present at
28 contig ends. Gene annotation revealed 6,322 predicted protein-coding genes, which
is similar to the data from the seven other representative C. gattii isolates with publicly
available complete genomes (26, 27) representing the four previously known major
lineages (ranging from 6,092 to 6,763), as well as C. neoformans H99 (28) (n 6,962)
(Fig. S5 and S6).
To establish the evolution of protein-coding genes in C. gattii, we compared the
gene content data for two representative annotated genomes per lineage where
possible (no second annotated reference genomes were available for VGIV, VGV, and
VGVI), identifying 4,565 single-copy core orthologs that are shared among the five
lineages of C. gattii and C. neoformans (74% of Cryptococcus genes) (Table 2). For
VGVI, we sequenced and assembled the WM1802 isolate, obtaining a similar genome
length (17.42 Mb) and a similar count of protein-coding genes (n 6,092). For VGII, we
included the updated VGII R265 PacBio assembly in our panel of genomes (29) (Table 2).
Detection orthology analysis performed between just the two R265 assemblies iden-
tified 91% of genes in 1:1 orthology (n 5,642), 4% of genes unique to the new
assembly (n 252), and 6% of genes in paralogous clusters (n 364). The previous
VGII R265 assembly had 635 genes that were not called in the new assembly, likely
representing a difference in the annotation protocol. Analysis of core eukaryotic genes
(CEGs) and BUSCO revealed a high level of completeness of gene sets and increased
completeness in the new annotation (Fig. S6). Furthermore, all assemblies generated
using long-read sequencing technology assembled into 14 scaffolds/supercontigs,
suggesting that all Cryptococcus lineages/species have conserved numbers of chromo-
somes.
Ortholog amino acid differences within and between lineages were consistent
with results from our phylogenetic and population genetic analyses. VGV MF34 had
the highest amino acid sequence similarity to VGIV IND107 (53,000 amino acid differ-
ences 97.55% similarity), which was observed in both alignment-based and ortholog-
based phylogenies (Fig. 2 and Fig. 4). The most similar interlineage orthologs were
those of VGIII and VGVI (49,500 predicted amino acid differences  97.71% similarity)
(Table S1), while the most distinct pairwise comparisons were those between C. gattii
TABLE 2 The genome assemblies used for phylogenetic analysis and orthology detectiona
Species Lineage Isolate Genome ID
Genome
size (Mb)
No. of
contigs/scaffolds
No. of protein-
coding genes
C. gattii VGI WM276 CNB_WM276_v2 18.36 14 6,565
C. gattii VGI EJB2 Cryp_gatt_EJB2_V1 17.53 282 6,763
C. gattii VGII R265 Cryp_gatt_R265 17.55 14 6,192
C. gattii VGII Ram5 Cryp_gatt_Ram5_V1 17.32 24 6,463
C. gattii VGIII CA1280 Cryp_gatt_CA1280_V1 17.49 89 6,683
C. gattii VGIII CA1873 Cryp_gatt_CA1873_V1 17.39 33 6,634
C. gattii VGIV IND107 Cryp_gatt_IND107_V2 17.56 34 6,696
C. gattii VGV MF34 Cryp_gatt_MF34* 17.89 15 6,322
C. gattii VGVI WM1802 Cryp_deca_WM1802* 17.42 863 6,092
C. neoformans VNI H99 CNA2 18.87 14 6,962
aAsterisks (*) indicate genome assemblies that are newly described in this paper. All others have been described previously (26).
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and C. neoformans (between 205,000 and 218,000 amino acid changes; 90% protein
similarity).
Overall, synteny is conserved within C. gattii (26), though with notable differences
between some lineages. For example, VGV has a single 171-kb inversion on supercontig
7 (positions 544,906 to 716,249) compared with the middle of VGIV IND107 supercontig
7 and the middle of VGIII CA1280 supercontig 5 (Fig. 4). VGVI also has some syntenic
differences from its closest relative, VGIII (Fig. 2) (see also Fig. 3 and Fig. 4). For example,
approximately half of VGVI supercontig 5 is syntenic for the start of VGIII (CA1873)
supercontig 16, while the second half of VGVI supercontig 5 is syntenic for a middle
region of VGIII supercontig 1, indicative of a chromosomal translocation. Further
improvements and additional genome assemblies should establish the full number and
genetic impact of lineage-specific genomic rearrangements.
Lineage-specific genes and multilineage-specific genes (found in two or more
lineages) were identified in each of the lineages (Fig. 3f; see also Fig. S7). Many of these
lineage-specific genes (223/605; 37%) were previously identified from a panel of
genome assemblies without the addition of VGV and VGVI (26). A further 53/605
(9%) of the newly detected lineage-specific genes were previously categorized as
multilineage-specific genes. The lineage-specific genes in newly sequenced lineages (VGV
and VGVI) include 74 genes that were unique to VGV and 49 genes that were uniquely
absent in VGV. Genes unique to VGV include those encoding two sugar transporters
(D1P53_002216 and D1P53_002944), an alcohol dehydrogenase (D1P53_004471), and an
aldehyde dehydrogenase (D1P53_006242). Conversely, eight transmembrane proteins
and a single uncharacterized secreted protein were uniquely missing in VGV. All of the
genes involved in the ergosterol biosynthesis pathway were present in single-copy
FIG 4 A phylogenetic tree for 10 Cryptococcus genomes belonging to the six C. gattii lineages and 1 C. neoformans lineage outgroup alongside their genome
synteny. The phylogenetic tree was constructed in RAxML, with branch lengths indicating the mean number of nucleotide substitutions per site. To the right
is a synteny plot, visualizing regions that span three or more orthologs between any two species as a connected gray line. Supercontig numbers are shown
above each genome axis if longer than 400 kb, where a plus sign () represents the forward orientation and a minus sign (–) represents the negative orientation.
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form in VGV. The VGVI WM1802 genome includes 80 genes that are unique and lacks
127 genes that are uniquely absent. Among the unique genes in WM1802, 14 are
predicted to be involved in transport and include genes encoding three monosaccha-
ride transporters, one hexose transporter, one cadmium ion transporter, and one
monocarboxylic acid transporter.
Predictably, C. neoformans VNI H99 had the greatest number of lineage-specific/
absent genes, with 578 unique genes and 28 absent genes. These included 47 genes
predicted to encode transmembrane proteins (including four sugar transporters, five
major facilitator superfamily [MFS] transporters, and a caffeine resistance transporter),
and 34 secreted proteins. Fewer genes were uniquely absent in C. neoformans, which
included genes encoding eukaryotic translation initiation factor 3 subunit B, an ACC
oxidase, a copper amine, an allantoate permease of the major facilitator, and a
3-hydroxyacyl-dehydrogenase with oxidoreductase activity. Full details of all lineage-
specific genes are provided in Table S1.
Phenotypic characteristics of VGV. All six isolates that belonged to the new VGV
lineage based on whole-genome sequencing (Table 1) were first incorrectly identified
as VGIV based on the URA5 restriction fragment length polymorphism (RFLP) banding
pattern. Unlike most of VGIV, all six VGV isolates were serotype B. These were further
characterized as MAT and as melanin and urease positive (Fig. S8) and grew well at
37°C (Fig. 5A). However, the VGV strains grew slightly more slowly on canavanine
glycine bromothymol blue (CGB) agar (Fig. S8) than the serotype C VGIV strain (MF46)
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FIG 5 Phenotypic characteristics. (a) Growth of six VGV isolates and two VGIV control isolates at 30°C and 37°C on YEPD agar. (b) India ink staining
of VGV cells grown in YEPD broth for 24 h at 30°C. The isolates of clade A (MF5, MF13, and MF53) produced thinner capsules than the isolates
of clade B cells, which produced capsules similar in size to those produced by the two VGIV control isolates. Bar  5 m. (c) MIC of VGV isolates
for FLC, 5-FC, and amphotericin B. All tested isolates showed high FLC MICs ranging from 20 to 256 g/ml. The MIC for 5-FC was low, except for
MF46, an environmental isolate of VGIV, for which the MIC for 5-FC averaged 4 g/ml. All VGV isolates showed higher MICs for amphotericin B
than for the VGIV controls. (d) Survival curve of mice infected by four VGV isolates (intrapharyngeal aspiration of 5,000 cell/mouse) and two VGIV
control isolates. Only the mice infected with VGIV isolate WM779 succumbed to infection. (e) Lung (left) and brain (right) fungal loads. VGV
isolates grew moderately well in lungs, but the CFU levels in the brains were negligible.
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isolated from the same environment in the Central Miombo Woodland (Table 1). Hence,
the positive blue/green color development on CGB agar took longer in VGV than in the
control strains (Fig. S8). Since VGV is genetically closest to VGIV (Fig. 2a and b; see also
Fig. S2), two serotype C VGIV strains were used as control isolates for further phenotypic
comparisons (WM779 isolated from a cheetah in South Africa [16] and MF46 isolated
from Miombo tree bark in Zambia near Hyrax middens) (Table 1).
The size and morphology of VGV yeast cells were typical for Cryptococcus and
indistinguishable from those of cells of the control strains (Fig. 5B). Two distinct
patterns of capsule formation were found among the six VGV isolates grown in yeast
extract-peptone-dextrose (YEPD) broth (Fig. 5B). The isolates recovered from clade A
(MF5, MF13, and MF54) produced thinner (1-m-thick) capsules than those recovered
from clade B (MF34, MF51, and MF56), which produced thick (2-to-4-m-thick) capsules
similar to those seen with the VGIV control strains.
The VGV isolates and the control strains of VGIV manifested unusually high resis-
tance toward fluconazole (FLC), particularly given that they were sampled from an
environmental niche. The three isolates of VGV clade A were more resistant to FLC, with
drug MICs of 128 g/ml, than the three isolates in clade B, which showed drug MICs
of 24 to 64 g/ml. All six VGV isolates showed a drug MIC of 0.0625 g/ml for
5-fluorocytocine (5-FC), a value similar to that shown by WM779. The drug MIC of MF46
for 5-FC, 4 g/ml, was unusually high. The VGV amphotericin B MIC ranged between 0.5
and 1 g/ml, higher than the levels measured for the control strains, which showed
drug MICs below 0.5 g/ml (Fig. 5C).
To explore the relative pathogenicities among VGV subclades we selected two
isolates from clade A (MF5 and MF13) and two isolates from clade B (MF34 and MF51)
for inoculation in mouse models. Mice infected by all four isolates survived for 70 days,
while all the mice infected by WM779, a virulent serotype C control isolate, succumbed
to infection within 30 days postinfection (Fig. 5D). VGIV environmental isolate MF46
(serotype C) caused no death in the mouse model. Fungal loads in the lungs of
VGV-infected mice were substantially lower than those seen with the mice infected
with WM779 and slightly lower than those seen with the mice infected with MF46. Brain
fungal loads of mice infected with the VGV strains were also low to negligible. The
control isolates of VGIV showed little neurotropism (Fig. 5E). Histopathological analysis
of the lungs demonstrated significant pathology in WM779-infected mice, with yeast
found throughout the lung together with notable disruption of lung tissue. In many
locations, extensive leukocyte recruitment was evident in areas of concentrated infec-
tion (Fig. 6).
Histopathological analysis of the VGV isolates displayed substantially lower pulmo-
nary yeast levels. That said, mice infected by MF46, MF34, and MF51 had higher levels
of yeast than those infected by MF5 and MF13 as shown by both CFU counts (Fig. 5E)
and the results of histopathological analysis (Fig. 6), in which MF51 was shown to
represent clade B. The lung histopathology of the mice infected by MF34 was similar to
that of the mice infected by MF51 (data not shown). Notable for its absence, leukocyte
infiltration was mostly low or absent from sites of VGV infection. MF13 showed some
leukocyte infiltration to a subset of infectious foci (Fig. 6).
Identification of VGV by URA5 RFLP. The patterns of URA5 RFLP, obtained by
double digestion with Sau96I and HhaI, have been widely used to identify the lineage/
molecular type in both C. neoformans and C. gattii species complexes (14). The URA5
RFLP of clade A isolates obtained by Sau96I/HhaI digest showed a pattern identical with
that of VGIV (Fig. S9A). Those of clade B, however, produced an additional 1.3-kb
amplicon which was absent from clade A and from all of the other VG molecular type
reference isolates. This 1.3-kb amplicon was present even in uncut DNA of clade B
isolates (Fig. S9A and B), but its nature is not known at this juncture. Since the URA5
RFLP patterns of VGIV and VGV were not conclusively different, we compared the URA5
gene sequence of VGV isolate MF34 to that of VGIV reference strain WM779 to identify
possible restriction enzymes that can clearly distinguish the two lineages. This led to
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our identifying two highly discriminatory restriction enzymes: StuI and EarI. The ex-
pected sizes (measured in base pairs) of the URA5 gene fragments resulting from StuI
digestion are as follows: 221 bp, 237 bp, and 322 bp in VGIV and 237 bp and 543 bp in
VGV. The EarI digestions produced 247-bp and 501-bp fragments in VGIV and 247-bp
and 300-bp fragments in VGV. We compared URA5 RFLP data from 17 VGIV isolates
(Table S1) with the data from 6 VGV isolates obtained by StuI or EarI digestion, and the
results are shown in Fig. S9C and D.
Type strain of VGV. We have designated MF34 (clade B isolate) as the type strain
of VGV. MF34 was isolated from a tree hole located in Mutinondo (latitude 12.45,
longitude 31.29), Central Zambezian Miombo Woodlands (Table 1). Its genome has
been assembled and annotated to near-completion (15 scaffolds with N50 1.3 Mb and
telomeric repeats at 28 contig ends). MF34 is serotype B and MAT and causes mild
pneumonia in C57BL/6 mice with negligible neurotropism.
DISCUSSION
Over the past decade, increased sampling worldwide and whole-genome sequenc-
ing (WGS) methods have uncovered greater genetic diversity of important pathogens,
Alcian Blue, 2.5X Alcian Blue,10X H&E, 10X
VGV D20 LUNGS
Bar, 50μm (X10 magnification) and 200μm (X2.5 magnification)
VGIV
WM779
VGIV
MF46
VGV
MF5
VGV
MF13
VGV
MF51
FIG 6 Histopathology of lung infected by VGV isolates. Sections of the mouse lungs infected by three
different VGV isolates and two VGIV control strains were stained with alcian blue and periodic acid-Schiff
stain and counterstained with hematoxylin (left and middle columns) or with standard hematoxylin and
eosin (right column). Note that alcian blue stains cryptococcal cells blue. Images in the left columns were
acquired using a 2.5 objective. Images in the middle and right columns are higher-magnification (10)
images of the areas indicated by the yellow boxes in the 2.5 images.
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including the C. neoformans and C. gattii species complexes. For example, sampling
from Botswana revealed the existence of the C. neoformans VNB lineage (30), which
itself has recently been shown to be deeply split into two genetically isolated lineages,
VNBI and VNBII (31). Thus far, VGVI is the only lineage that exists as a single genotype
since the three isolates previously designated C. decagattii appear to have been isolated
from the same patient (21). The previously identified lineages of Cryptococcus have
recently been designated separate taxonomic species based on phylogenetic species
recognition criteria (17). While we agree that Cryptococcus contains a number of
genetically diverse and monophylectic clades that can be viewed as species under an
evolutionary species concept (32), we have previously argued that it is premature to
give each clade a separate taxonomic name at this juncture (18, 33). One notable
concern raised by Kwon-Chung et al. (18) was that the proposed seven-species taxon-
omy (33) was likely to be unstable due to incomplete knowledge of the true extent of
Cryptococcus diversity worldwide. Our discovery of C. gattii VGV from the Miombo
woodlands of Zambia clearly shows that we have not yet achieved a full understanding
of the global biodiversity of Cryptococcus and that further exploration will likely yield
additional phylogenetic species. Until we have a more accurate consensus on the true
numbers of Cryptococcus lineages, we propose that the names “VN” and “VG” serve as
practical “Zip code” identifiers within C. neoformans and C. gattii, offering a convenient
way to describe newly discovered lineages or recombinants without introducing
unwanted nomenclatural instability and confusion.
Our discovery of C. gattii VGV in samples from hyrax-associated environments
suggests an association with these mammals. Hyrax are small herbivores that are most
closely related to elephants (Proboscidea) and sea cows (Sirenia) and are characterized
by the behavior of defecating in communal latrines, usually located in crevices in rocky
kopjes, over many generations (34). These locations are often sheltered in rocky caves
and droppings are likely to accumulate for upwards of 50,000 years, in some cases
forming a stable paleoenvironmental hot spot of urea-rich nitrogenous material (35).
Cryptococcus has a pronounced trophism for urea as a nutritive substrate, and pigeon
guano is known to support prolific growth of C. neoformans and (to a lesser extent) C.
gattii (36). Our finding that hyrax middens are hotspots of Cryptococcus diversity
suggests that their ecological stability in landscapes that are low in nitrogen availability
may lead to them being important arenas for the evolution of Cryptococcus and that
they will likely be fertile ground for further discovery of diversity within this genus.
Fungal association with small mammals may suggest adaptations that confer patho-
genicity, known as the “endozoan, small-mammal reservoir” hypothesis (37), and
deserves to be explored further following our findings of an association of Cryptococcus
with hyrax. Accordingly, alongside further study of potential mammalian reservoirs, the
search for VGV clinical isolates is also needed in order to understand the true virulence
potential of VGV and whether it can spill over into humans. Murine models have shown
that environmental isolates are less virulent than clinical isolates of the same molecular
type in both the C. gattii and C. neoformans species complexes, suggesting that
polymorphic virulence factors exist (38, 39). However, despite its great genetic distance
from all other lineages, the new VGV lineage is not clearly distinguishable from others
by existing methods such as serotyping or the routinely used approach of RFLP analysis
employing Sau96I and HhaI URA5 digestion (14). Thus, it is possible that previously
analyzed isolates belonging to VGV may have been misidentified using non-WGS
methods. The most likely candidates for the search of clinical VGV are VGIV serotype B
isolates recovered from patients. Geographically, the most likely place to find the VGV
clinical isolates appear to be in sub-Saharan Africa since the current panel of isolates
were found in the Zambian environment within an ecoregion that includes Tanzania,
Burundi, Democratic Republic of the Congo, Angola, and Malawi.
Previous work has shown that most isolates of the C. gattii species complex cause
pulmonary infection in a murine model with low neurotropism (20, 40, 41). The four
VGV isolates tested here were less neurotropic than the MF46 VGIV isolate that was
collected from the same Zambian environment, and all the examined Zambian envi-
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ronmental isolates were significantly less virulent than a VGIV control strain, WM779. It
remains to be shown whether the differences in neurotropism are due to lineage-
specific genes or to alleles in VGV. As previous work has shown in C. neoformans (42),
capsule size difference manifested by clades A and B in vitro was unrelated to virulence
in mice.
Although serotypes have not yet been conclusively linked to virulence in Crypto-
coccus, they remain important for strain identification. The majority of C. gattii isolates
tested to date have been of serotype B, except for a subset of VGIII and the majority of
VGIV isolates, which are serotype C. The six VGV isolates are also all serotype B—but,
due to the lower growth rate on CGB agar, the CGB reaction was weaker than that seen
with other isolates of serotype B or serotype C. It took 24 h longer for VGV than for the
other VG isolates (VGI to VGIV) to turn the medium dark blue. As the six VGV isolates
were all serotype B whereas the majority of VGIV isolates (the most closely related
lineage) reported thus far have been serotype C, it is possible that VGV may also occur
in serotype C. Additional environmental sampling of VGV is therefore necessary to
establish the dominant serotype, since the current sample size of six is insufficient for
definitive conclusions.
Surprisingly, five of the six VGV isolates and the two control VGIV isolates were
highly resistant to fluconazole (MIC of 64 g/ml), a commonly used antifungal drug.
The three isolates of VGV clade A were more resistant to FLC than the isolates of VGV
clade B. Although the C. gattii species complex was previously known to be more
resistant to FLC on average than C. neoformans (43), such high resistance to FLC in
environmental isolates is notable and was not previously reported (44). All of the VGV
isolates had identical nucleotide sequences for ERG11 and AFR1, demonstrating that the
resistant isolates did represent not a result of genetic differences in the target or
transporter of FLC. However, innate fungal resistance to FLC can be due to multiple
factors besides the ERG11 gene or efflux pumps and the mechanism(s) of FLC resistance
in VGV remains a subject for future investigation. Why environmental VGV isolates
should have such high resistance to azoles is unclear, as, given the relatively pristine
environments from which they were recovered, it is unlikely that they had come into
contact with agrichemicals. More likely, fluconazole resistance is a pleiotrophic effect
that has evolved as a consequence of exposure to xenobiotics other than azoles.
Further investigations into the evolution of FLC resistance in VGV may take on addi-
tional importance as clinical cases due to VGV are a distinct possibility in the Sub-
Saharan regions where 12% of the members of the Zambian population are living with
the HIV (https://www.unaids.org/en/regionscountries/countries/zambia).
In this paper, we present a nearly complete genome assembly for VGV type strain
MF34. The MF34 genome allowed us to conclusively establish that VGV is a lineage of
C. gattii that is separate and distinct from any previously identified and that it is not the
result of hybridization, as has been seen for other divergent isolates (31). Indeed, while
both Cryptococcus species complexes appear to have a conserved chromosome num-
ber of 14 based on the current panels of assembled and annotated genomes available,
intrachromosomal and interchromosomal rearrangements as well as large CNVs appear
to be common. This chromosomal variation may provide the genetic basis for pheno-
typic variation and may act as a genetic barrier to recombination between more highly
divergent isolates such as those from separate lineages. At the within-lineage level,
there are also a number of unique and uniquely lost “lineage-specific” genes which may
contribute to phenotypic differences between lineages. However, it should be noted
that many of the main phenotypes routinely measured, including virulence in animal
models, growth rates, and ability to cause pulmonary versus central nervous system
(CNS) infections, appear to differ as much within as between lineages.
One line of future inquiry that may help to explain this phenotypic diversity may
come from the characterization of further transcriptional differences. For example, VGII
has been shown previously to upregulate many of the ergosterol genes during coin-
cubation with bone-marrow derived macrophages (45) and it will be important to
determine whether other traits exist which differentiate the lineages of Cryptococcus.
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Further, it will be important to examine whether similar lineage-specific differences
underpin VGV’s increased FLC resistance and whether clinically relevant traits such as
drug resistance are linked to the environment within which these isolates have evolved.
Ultimately, our report testifies to the deep reservoir of diversity that exists within
Cryptococcus, which, despite decades of research into this genus, still harbors abundant
surprises.
MATERIALS AND METHODS
Library preparation and sequencing of Zambian isolates. Environmental sampling took place in
January and September of 2013. Samples were collected using Transwab Amies swabs (MWE; code
MW170) and sterilized 30-ml screw-cap glass bottles. Amies liquid transport swabs were taken from tree
bark (n 20), soil (n 19), and cracks in granite kopjes or droppings from rock Hyrax middens (n 16).
Samples were collected and processed according to previously established protocols (46, 47), and the
samples were kept at 4°C before being processed on niger seed agar. All samples were collected under
license from the Zambian Wildlife Authority (ZAWA).
Single colonies purified from the original isolation media were maintained under cryopreservation
conditions at –80°C at Imperial College in London since 2013. The isolates were has been changed to
revived on YPD agar (yeast extract 1%, peptone 1%, dextrose 2%) and incubated at 30°C before use.
Genomic DNA was isolated with the cetyltrimethylammonium bromide (CTAB) extraction method as
described previously (48) with modifications. Paired-end libraries (150 bp) were prepared and sequenced
using an Illumina HiSeq 4000 platform by Novogene (Davis, CA). Two Oxford Nanopore libraries of isolate
MF34 were constructed from genomic DNA using a one-dimensional (1D) library construction kit (model
no. SQK-LSK109). A total of 243,660 reads with an N50 of 9,827 were generated on a FLO-MIN106 flow cell
using a Minion. Reads were base called using Albacore v2.3.1. This resulted in 923,997,900 total bases
(46 coverage).
Genome assembly and annotation. For isolate MF34, a hybrid assembly of Oxford Nanopore long
reads and Illumina short reads was generated. An initial assembly of the Oxford reads was generated
using Canu v1.5 (49) with parameter genomeSize 20,000,000. The assembly was inspected for the
presence of telomeric repeat (TTAGGG) at contig ends; for two contig ends missing a telomeric repeat,
contigs were extended by aligning unassembled Canu contigs to these ends using NUCmer v3.1 (50).
Base-called reads were then aligned to the contigs using the Burrows-Wheeler transform algorithm (BWA
mem) (51) with flag “-x ont2d” and the alignments used for polishing with nanopolish (52). Two rounds
of Pilon v1.13 (53) correction were performed using Illumina BWA read alignments (51). Paired Illumina
sequences of C. decagattii (VGVI) were assembled and scaffolded using SPAdes v3.1.1 (54) with k-mer
lengths of 21, 33, 55, and 77. A summary of statistics for the assembly is provided in Table 2. Reads were
aligned to the assembly with BWA v0.7.4-r385 mem (51), and Pilon v1.12 (53) was further used to improve
the assembly. Scaffolds that were less than 1 kb were removed. The genome assembly has been
submitted to NCBI (see below for project accession number).
The C. gattii VGV MF34 and VGVI WM1802 genomes were annotated using Genemark (55), BLASTx
against Swiss-Prot (56) and KEGG (57), and HMMER hmmscan (58) against PFAM (59). We ran tRNAscan
(60) and RNAmmer (61) to identify non-protein-coding genes. Gene predictions were checked for a
variety of issues, including overlapping of noncoding genes, overlapping of coding genes, and the
presence of in-frame stops. Genes were named according to evidence from BLASTx and HMMER in the
following order of precedence: (i) Swiss-Prot (56), (ii) TIGRfam (62), and (iii) KEGG (57) (where BLASTx hits
must meet the 70% identity and 70% overlap criteria to be considered a good hit and for the name to
be applied). Otherwise, genes were classified as hypothetical proteins.
Genes were functionally annotated by assigning PFAM domains (59), GO terms, KEGG assignment,
and ortholog mapping to genes of known function. HMMER3 (58) was used to identify PFAM (release 27)
domains, and BLASTx was used against the KEGG v65 database (57) (E value,1 1010). GO terms were
assigned using Blast2GO version2.3.5 (63), with a minimum E value of 1 1010. SignalP 4.0 (64) and
TMHMM (65) were used to identify secreted proteins and transmembrane proteins, respectively (see
Fig. S5 in the supplemental material). Gene sets were aligned to the 248 core eukaryotic genes (CEGs)
and BUSCO basidiomycota_odb9 set to evaluate completeness (Fig. S6).
Read alignment and variant identification. The 36 newly sequenced isolates from this study were
compared to an additional 65 isolates that had been sequenced and described in previous studies (20,
26, 38, 66, 67). These additional isolates were obtained from the NCBI Sequence read archive (SRA) and
converted from SRA format to FASTQ using SRA Toolkit version 2.3.3-4. Illumina reads were aligned to
the C. gattii VGII R265 reference genome assembly using Burrows-Wheeler Aligner (BWA) v0.7.4-r385
mem (51) with default parameters and were converted to sorted BAM format using SAMtools v0.1.9
(r783) (68).
Genome Analysis Toolkit (GATK) v2.7-4-g6f46d11 (69) was used to call both variant and reference
nucleotides from the 101 alignments (as previously described [24]). Briefly, the Picard tools AddOr-
ReplaceReadGroups, MarkDuplicates, CreateSequenceDictionary, and ReorderSam were used to prepro-
cess the alignments (http://broadinstitute.github.io/picard/). GATK RealignerTarget-Creator and IndelRe-
aligner were then used to resolve misaligned reads close to indels. Next, GATK Unified Genotyper (with
the haploid Genotyper ploidy setting) was run with both SNP and indel genotype likelihood models
(GLM). We also ran Base Recalibrator and PrintReads for base quality score recalibration on those initial
sites for GLM SNP. We then recalled variants with Unified Genotyper with the parameter “—output-
_mode EMIT_ALL_SITES.” We merged and sorted all of the calls and then ran Variant Filtration with the
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parameters “QD 2.0, FS 60.0, MQ 40.0.” Next, we removed any base that had a minimum genotype
quality of below 50, a minimum proportion of alternative alleles (AD) of 80%, or a minimum depth of 10.
Finally, we removed any positions that were called by both GLMs (i.e., incompatible indels and SNPs), any
marked “LowQual” by GATK, any nested indels, and any sites that did not include a PASS flag.
Phylogenetic and population genetic analysis. The variants identified from the 101 alignments
were filtered for positions that were homozygous (reference or SNP) and polymorphic in at least one
isolate (Fig. 2), resulting in alignment of 1,517,353 nuclear sites and 970 mitochondrial sites. A FASTA file
of these positions was created and converted into PHYLIP format, and a phylogenetic tree was generated
using RAxML v7.7.8 (70) with 1,000 bootstrap replications. RAxML was run with the generalized
time-reversible (GTR) and category (CAT) rate approximation, with final evaluation of the tree performed
using GTR plus gamma-distributed rates. The same sites were analyzed using the NeighborNet Network
of SplitsTree v4.14.6 (71).
A multisample variant call format (VCF) corresponding to all 101 genomes was made with VCFtools
(72) and converted to ped and map file formats for use in PLINK v1.90 (73). Unsupervised ADMIXTURE
(74) was run on a moderately linkage disequilibrium (LD)-pruned alignment for values of K between 1
and 15. A value of K 9 provided the lowest cross-validation error (Fig. 3d and e; see also Fig. S1). To
explore finer patterns of population structure among our sampled lineages, we applied a technique
designed to characterize patterns of haplotype sharing between panels of “donor” and “recipient”
haplotypes within a recombining population. We ran Chromopainter v2 (23) to infer, at each position in
a recipient isolate’s genome, the donor to which it is most closely ancestrally related relative to all others
in the data set. To do this, we assumed a uniform recombination rate of 1.5 M (morgans)/megabase
based on the genome-wide recombination rate previously estimated in C. neoformans (75) and with
Chromopainter’s switch and mutation rate parameters estimated using 10 runs of expectation-
maximization (n 190.29; M 0.0011). We then ran Chromopainter in linked mode using the haploid
switch (-j) under an “all-versus-all” framework, painting all samples using all others to produce a pairwise
coancestry matrix describing the amount of DNA matches of each isolate to every other under the
copying model.
Haplotype-based clustering was then implemented in fineSTRUCTURE (23) with an estimated nor-
malization parameter of c 0.51, sampling cluster assignments every 10,000 iterations for 1 106
Markov chain Monte Carlo (MCMC) iterations after 1 106 initial burn-in steps. We then performed an
additional 1 105 hill-climbing iterations beginning with the MCMC sample with the highest posterior
probability. This classified our data into 34 clusters (Fig. S2).
For the C. neoformans VNI H99-rooted C. gattii tree, we identified 1:1 orthologs for each of the nine
isolates with Orthofinder v2.1.2 (76) using the Synima pipeline (77). We aligned orthologs with MUSCLE
v3.8.31 (78), extracted the coding DNA sequences (CDSs) in a codon context, trimmed to the smallest
contiguous sequence, and then concatenated alignments. In total, we aligned 2.16 Mb of transcripts for
each genome. Prottest v3.4 (79) was used to determine the best-fitting amino acid transition model (JTT)
according to Bayesian information criterion. The final tree was produced using RAxML v7.7.8 (70) and the
CAT rate approximation and WAG amino acid replacement matrix with 1,000 bootstrap replicates.
Synima (77) was used to visualize synteny between the genomes. The same pipeline was used to
compare the previous and updated R265 genomes.
Phenotypic analysis. To determine the growth rate of C. gattii VGV, cells of all six VGV isolates were
inoculated in YEPD broth and incubated at 30°C on a shaker (200 rpm) for 18 h. Cells were washed with
sterile phosphate-buffered saline (PBS), and 2 105 cells/ml were resuspended in PBS. Three-microliter
aliquots of 10-fold serial dilutions were spotted onto YEPD agar and incubated at 30°C and 37°C. For
biological confirmation of the species, isolates were inoculated on canavanine glycine bromothymol blue
(CGB) agar (80) for species-specific CGB reactions and on Christensen’s urea agar (Sigma) and norepi-
nephrine agar (81) for urease and melanin production reactions, respectively, and were incubated at 30°C
for 48 h. India ink staining of the cells grown on YEPD broth for 24 h at 30°C was used for microscopic
observation of the cell and polysaccharide capsule size. The reference strains used were WM148 or H99
(serotype A, VNI), WM626 (serotype A, VNII), WM179 (serotype B, VGI), WM178, R265 and R272 (serotype
B, VGII), WM161 (serotype B, VGIII), and WM779 (serotype C, VGIV) (14). The mating type of each isolate
was determined by PCR using primers specific to STE12 and STE20a (82).
Determination of MIC for antifungal antibiotics. MICs for fluconazole (FLC), 5-fluorocytosine (5FC),
and amphotericin B were determined using Etest strips according to the Etest technical guide (AB
Biodisk, Solna, Sweden), with slight modification. Fungal cells were grown in 5 ml of YEPD at 30°C for
18 h. Harvested cells were diluted in sterile saline solution to an optical density at 600 nm (OD600) of 0.05
and plated on yeast nitrogen base (YNB) agar plates. Etest strips were placed at the center of the plates
and incubated at 30°C for 72 h. The susceptibility endpoint was read at the first growth inhibition ellipse.
The concentration ranges tested were as follows: for FLC, 0.016 to 256 g/ml; for both 5-FC and
amphotericin B, 0.002 to 32 g/ml.
URA5 gene RFLP. The URA5 gene of each isolate was amplified from genomic DNA by PCR to identify
the molecular type using 50 ng of two primers: URA5 (5=-ATGTCCTCCCAAGCCCTCGACTCCG-3=) and SJ01
(5=-TTAAG ACCTCTGAACACCGTACTC-3=). Reactions were carried out in a total volume of 50 l as
previously described (14). PCR was performed for 40 cycles at 94°C for 2 min of initial denaturation, 30 s
of denaturation at 94°C, 30 s of annealing at 55°C, and 2 min of extension at 72°C. The reactions were
completed by performing a final extension step for 10 min at 72°C. PCR products were analyzed by 1%
agarose gel electrophoresis, and 5 l of PCR products was double digested with Sau96I (10 U/l) and
HhaI (20 U/l) for 3 h at 37°C. Then, digested samples were separated by 3% agarose gel electrophoresis
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at 80 V for 5 h. The RFLP patterns of URA5 gene were analyzed using well-defined bands in the gel images
by comparing them with the patterns obtained from the standard reference strains.
Restriction enzyme analysis of the URA5 gene to distinguish VGV from VGIV. We found that the
URA5 RFLP banding patterns (14) of VGV and VGIV were not clearly distinguishable using Sau96I and HhaI
(Fig. S9A). We compared the DNA sequences of the URA5 gene from MF34 (VGV) and WM779 (VGIV) and
found two restriction enzymes, StuI and EarI, that can be used to distinguish the two molecular types
based on URA5 RFLP. Three microliters of URA5 PCR products was digested with StuI (10 U/l) or EarI
(20 U/l) (New England BioLabs Inc.) at 37°C for 4 h, and restriction fragments were separated by
electrophoresis in 3% agarose Tris-acetate-EDTA (TAE) gels at 80 V for 5 h. Standard reference strains for
molecular typing were used as controls.
Virulence in mice. The virulence of four VGV isolates, two from clade A and two from clade B, was
assessed using 7-to-8-week-old female C57BL/6 mice (Taconic Farms). Isolates to be tested in mice were
inoculated in YEPD broth and incubated overnight, washed twice, and diluted in PBS to 2.5 105
cells/ml. Mice (14 per isolate) were inoculated with 20 l of cell suspension (5 103 cells/mouse) by
pharyngeal aspiration. Eight mice were used for each isolate for determination of the survival rate, and
six mice each were used for the analyses of fungal burden and histopathology at the indicated time
points. Mice were monitored twice per day, and differences in survival were determined using GraphPad
Prism, version 7 (GraphPad Software, San Diego, CA).
To assess the organ fungal burden, lungs and brains of four mice from each infected group were
inspected. The mice infected with WM779 started to die on day 25 postinfection, and the lungs and
brains were harvested immediately from the dead mice on day 25. Mice infected with other isolates were
euthanized on day 60, and organs were harvested. Harvested lungs and brains were homogenized in
7 ml and 2 ml of sterile water, respectively, and 5-l aliquots of 10-fold serial dilutions were plated on
YEPD agar and incubated at 30°C for 48 h. Fungal colonies were counted and the tissue fungal burden
was analyzed using GraphPad Prism, version 7 (GraphPad Software, San Diego, CA).
Histopathological analysis. For histopathological analysis, organs of infected mice from each group
were harvested at 10 and 20 days postinoculation and fixed in 3.7% buffered formalin and embedded in
paraffin. Sections were stained with hematoxylin and eosin (H&E) or alcian blue/periodic acid-Schiff
(AB/PAS) at Histoserv Inc.
Ethics statement. The Institutional Animal Care and Use Committee of the National Institute of
Allergy and Infectious Diseases approved all animal studies (approval no. LCIM-5E). Studies were
performed in accordance with recommendations of the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health.
Data availability. The raw sequence and genome assembly of VGV MF34 are available in NCBI under
BioProject accession no. PRJNA487802, and the culture has been deposited at the American Type Culture
Collection (accession number pending). Raw sequence data were submitted to the NCBI Sequence Read
Archive under BioProject identifiers (ID) PRJNA476154 (all C. gattii non-VGV isolates) and PRJNA480403
(all C. gattii VGV isolates).
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